ENCORE MEDICAL L.P.

Manufacturer adverse-event records for ENCORE MEDICAL L.P. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2003–2026 · mid-book · quiet Death-code · injury-heavy

Injury-mix signature

ENCORE MEDICAL L.P. leans injury-heavy in event_type mix

Injury-coded event_type share is 97.9% (injury-heavy tercile) beside 0.01% Death-coded (quiet). Volume band: mid.

What the Injury-mix reading shows for ENCORE MEDICAL L.P.

The standout signal for ENCORE MEDICAL L.P. is Injury-mix: 97.9% Injury-coded (injury-heavy) beside 0.01% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for ENCORE MEDICAL L.P.. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 9,771 (97.9% of event_type total). Peak single-year volume reaches 1,862 reports across 19 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

9,982
Total Reports
1
Event-type Death
9,771
Injury Reports
20
Device Types

Event Types

Injury 9,771 (97.9%)
Malfunction 188 (1.9%)
Other 22 (0.2%)
Death 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 7,648 (63.8%)
Other 1,615 (13.5%)
R 1,471 (12.3%)
Hospitalization 598 (5.0%)
O 453 (3.8%)
H 72 (0.6%)
66 (0.6%)
S 37 (0.3%)
Disability 25 (0.2%)
L 3 (0.0%)
Life Threatening 3 (0.0%)
D 1 (0.0%)
Death 1 (0.0%)

Yearly Trend

03
2003: 1
04
2004: 7
05
2005: 12
06
2006: 2
10
2010: 26
11
2011: 1
14
2014: 1
15
2015: 2
16
2016: 6
17
2017: 760
18
2018: 861
19
2019: 1,109
20
2020: 1,083
21
2021: 872
22
2022: 1,407
23
2023: 439
24
2024: 1,215
25
2025: 1,862
26
2026: 316